EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA

Hefen Chen iD, Zhujun Gong, Hong Zhou, Yong Han

Drug Development Research · 2024

DOI: 10.1002/ddr.22167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, 2024. Verfasst von Hefen Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is a primary malignant bone tumor and is prevalent in children, adolescents, and elderly individuals. It has the characteristics of high invasion and metastasis. Neoadjuvant chemotherapy combined with surgical resection is the most commonly used treatment for OS. However, the efficacy of OS is considerably diminished by chemotherapy resistance. In recent years, noncoding RNAs (ncRNAs), including microRNAs, long noncoding RNAs, and circular RNAs, are hot topics in the field of chemotherapy resistance research. Several studies have demonstrated that ncRNAs are substantially associated with chemoresistance in OS. Thus, the present study overviews the abnormally expressed ncRNAs in OS and the molecular mechanisms involved in chemoresistance, with an emphasis on their function in promoting or inhibiting chemoresistance. ncRNAs are expected to become potential therapeutic targets for overcoming drug resistance and predictive biomarkers in OS, which are of great significance for enhancing the therapeutic effect and improving the prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOsteosarcomaBone NeoplasmsAdolescentChildAgedHumansDrug Resistance, NeoplasmRNA, Untranslated

Stichwörter der Autor:innen

chemoresistancenoncoding RNAosteosarcoma

Substanzen

MicroRNAsRNA, Untranslated

Autor:innen und Institutionen

  • Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Pharmacy, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Hefen Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Gong, Z., Zhou, H., & Han, Y. (2024). Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA. Drug Development Research. https://doi.org/10.1002/ddr.22167

Vancouver

Chen H, Gong Z, Zhou H, Han Y. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA. Drug Development Research. 2024. doi:10.1002/ddr.22167

BibTeX
@article{Chen2024,
  author = {Chen, Hefen and Gong, Zhujun and Zhou, Hong and Han, Yong},
  title = {Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22167}
}
Kostenlos starten →